145 related articles for article (PubMed ID: 36216527)
1. Teaching Video NeuroImage: Disabling Jaw Clonus in a Patient With Bulbar-Onset Amyotrophic Lateral Sclerosis Successfully Treated With Botulinum Toxin.
Oliveira Santos M; Schön M; Valadas A; de Carvalho M
Neurology; 2022 Oct; 99(15):671. PubMed ID: 36216527
[No Abstract] [Full Text] [Related]
2. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
[TBL] [Abstract][Full Text] [Related]
3. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.
Bushara KO
Med Hypotheses; 1997 Apr; 48(4):337-9. PubMed ID: 9160288
[TBL] [Abstract][Full Text] [Related]
4. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.
Oliveira AF; Silva GA; Almeida DM
Einstein (Sao Paulo); 2016; 14(3):431-434. PubMed ID: 27759834
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
Verma A; Steele J
Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
[TBL] [Abstract][Full Text] [Related]
6. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.
Giess R; Naumann M; Werner E; Riemann R; Beck M; Puls I; Reiners C; Toyka KV
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):121-3. PubMed ID: 10864618
[TBL] [Abstract][Full Text] [Related]
7. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.
Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I
Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147
[TBL] [Abstract][Full Text] [Related]
8. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
Guidubaldi A; Fasano A; Ialongo T; Piano C; Pompili M; Mascianà R; Siciliani L; Sabatelli M; Bentivoglio AR
Mov Disord; 2011 Feb; 26(2):313-9. PubMed ID: 21259343
[TBL] [Abstract][Full Text] [Related]
10. Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.
Kent L; Davies P; Kennett R; Wimalaratna S; Kerr R; Turner MR; Talbot K
J Neurol; 2013 Apr; 260(4):1166-7. PubMed ID: 23400499
[No Abstract] [Full Text] [Related]
11. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
[TBL] [Abstract][Full Text] [Related]
12. The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review.
Squires N; Humberstone M; Wills A; Arthur A
Dysphagia; 2014 Aug; 29(4):500-8. PubMed ID: 24847964
[TBL] [Abstract][Full Text] [Related]
13. Rhythmic Jaw Movements in Amyotrophic Lateral Sclerosis: Is It Clonus or Tremor?
Kumar R; Blackband J; Wagle Shukla A
Tremor Other Hyperkinet Mov (N Y); 2024; 14():8. PubMed ID: 38434715
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
[TBL] [Abstract][Full Text] [Related]
15. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
Tan EK; Lo YL; Seah A; Auchus AP
J Neurol Sci; 2001 Sep; 190(1-2):95-7. PubMed ID: 11574113
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach.
Winterholler MG; Erbguth FJ; Wolf S; Kat S
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):417-8. PubMed ID: 11248905
[No Abstract] [Full Text] [Related]
17. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
Young CA; Ellis C; Johnson J; Sathasivam S; Pih N
Cochrane Database Syst Rev; 2011 May; (5):CD006981. PubMed ID: 21563158
[TBL] [Abstract][Full Text] [Related]
18. The Role of Radiation Therapy and Botulinum Toxin Injections in the Management of Sialorrhea in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review.
Shehee L; O'Rourke A; Garand KL
J Clin Neuromuscul Dis; 2020 Jun; 21(4):205-221. PubMed ID: 32453096
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study.
Vázquez-Costa JF; Máñez I; Alabajos A; Guevara Salazar M; Roda C; Sevilla T
J Neurol; 2016 Oct; 263(10):1954-60. PubMed ID: 27383643
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.
Neppelberg E; Haugen DF; Thorsen L; Tysnes OB
Eur J Neurol; 2007 Dec; 14(12):1373-7. PubMed ID: 17941851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
